COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Aim. To evaluate the effectiveness of fixed combination of bisoprolol and amlodipine in arterial hypertension (AH) with chronic obstructive pulmonary disease (COPD).Material and methods. The study of 38 patients performed with AH of 1-2 grades and COPD of the 2nd grade of severity, in remission. As...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Nikitin, E. V. Gosteva, L. V. Pyshnograeva, L. V. Vasilyeva
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2015-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/175
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250444277186560
author V. A. Nikitin
E. V. Gosteva
L. V. Pyshnograeva
L. V. Vasilyeva
author_facet V. A. Nikitin
E. V. Gosteva
L. V. Pyshnograeva
L. V. Vasilyeva
author_sort V. A. Nikitin
collection DOAJ
description Aim. To evaluate the effectiveness of fixed combination of bisoprolol and amlodipine in arterial hypertension (AH) with chronic obstructive pulmonary disease (COPD).Material and methods. The study of 38 patients performed with AH of 1-2 grades and COPD of the 2nd grade of severity, in remission. As antihypertensive drug the combination of bisoprolol and amlodipine was used. At the baseline and in 12 weeks of therapy the patients underwent 24-hour blood pressure monitoring (ABPM), echocardiography (EchoCG), spirometry.Results. In 12 weeks of therapy 34 (89,5%) patients continued taking the drug. Therapy led to target BP values in 32 (84,2%) of patients with average daily dosage 7,5/10 mg. ABPM analysis demonstrates the stability of antihypertensive effect and significant improvement of the parameters in long-term usage of bisoprolol+amlodipine. At the background of treatment there was tendency for normalization of diastolic heart function. In evaluation of spirometry tests before and after 12 weeks of therapy there were no any significant differences in values that means absence of negative influence of combination drug on bronchial conduction.Conclusion. The results confirm the significance of combination therapy usage in AH with COPD.
format Article
id doaj-art-293ce147ec194db4889728fcbd247b91
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2015-08-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-293ce147ec194db4889728fcbd247b912025-08-20T03:57:17Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252015-08-0114481210.15829/1728-8800-2015-4-8-12175COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEV. A. Nikitin0E. V. Gosteva1L. V. Pyshnograeva2L. V. Vasilyeva3SBEI HPE Voronezh State Medical Academy of the Healthcare Ministry. Voronezh, RussiaSBEI HPE Voronezh State Medical Academy of the Healthcare Ministry. Voronezh, Russia; City Clinical Hospital №20. Voronezh, RussiaCity Clinical Hospital №20. Voronezh, RussiaSBEI HPE Voronezh State Medical Academy of the Healthcare Ministry. Voronezh, RussiaAim. To evaluate the effectiveness of fixed combination of bisoprolol and amlodipine in arterial hypertension (AH) with chronic obstructive pulmonary disease (COPD).Material and methods. The study of 38 patients performed with AH of 1-2 grades and COPD of the 2nd grade of severity, in remission. As antihypertensive drug the combination of bisoprolol and amlodipine was used. At the baseline and in 12 weeks of therapy the patients underwent 24-hour blood pressure monitoring (ABPM), echocardiography (EchoCG), spirometry.Results. In 12 weeks of therapy 34 (89,5%) patients continued taking the drug. Therapy led to target BP values in 32 (84,2%) of patients with average daily dosage 7,5/10 mg. ABPM analysis demonstrates the stability of antihypertensive effect and significant improvement of the parameters in long-term usage of bisoprolol+amlodipine. At the background of treatment there was tendency for normalization of diastolic heart function. In evaluation of spirometry tests before and after 12 weeks of therapy there were no any significant differences in values that means absence of negative influence of combination drug on bronchial conduction.Conclusion. The results confirm the significance of combination therapy usage in AH with COPD.https://cardiovascular.elpub.ru/jour/article/view/175bisoprololamlodipinearterial hypertensionchronic obstructive pulmonary disease
spellingShingle V. A. Nikitin
E. V. Gosteva
L. V. Pyshnograeva
L. V. Vasilyeva
COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Кардиоваскулярная терапия и профилактика
bisoprolol
amlodipine
arterial hypertension
chronic obstructive pulmonary disease
title COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_full COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_fullStr COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_full_unstemmed COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_short COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
title_sort combination therapy with bisoprolol and amlodipine in treatment of arterial hypertension patients with chronic obstructive pulmonary disease
topic bisoprolol
amlodipine
arterial hypertension
chronic obstructive pulmonary disease
url https://cardiovascular.elpub.ru/jour/article/view/175
work_keys_str_mv AT vanikitin combinationtherapywithbisoprololandamlodipineintreatmentofarterialhypertensionpatientswithchronicobstructivepulmonarydisease
AT evgosteva combinationtherapywithbisoprololandamlodipineintreatmentofarterialhypertensionpatientswithchronicobstructivepulmonarydisease
AT lvpyshnograeva combinationtherapywithbisoprololandamlodipineintreatmentofarterialhypertensionpatientswithchronicobstructivepulmonarydisease
AT lvvasilyeva combinationtherapywithbisoprololandamlodipineintreatmentofarterialhypertensionpatientswithchronicobstructivepulmonarydisease